Cargando…
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
Immune-mediated cerebellar ataxias (IMCAs), a clinical entity reported for the first time in the 1980s, include gluten ataxia (GA), paraneoplastic cerebellar degenerations (PCDs), anti-glutamate decarboxylase 65 (GAD) antibody-associated cerebellar ataxia, post-infectious cerebellitis, and opsoclonu...
Autores principales: | Mitoma, Hiroshi, Manto, Mario, Hampe, Christiane S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341499/ https://www.ncbi.nlm.nih.gov/pubmed/30221603 http://dx.doi.org/10.2174/1570159X16666180917105033 |
Ejemplares similares
-
Immune-mediated cerebellar ataxias: from bench to bedside
por: Mitoma, Hiroshi, et al.
Publicado: (2017) -
Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017) -
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
por: Hadjivassiliou, Marios, et al.
Publicado: (2022) -
Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias
por: Hadjivassiliou, Marios, et al.
Publicado: (2020) -
Guidelines for treatment of immune-mediated cerebellar ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2015)